Intent to Sole Source - 4 Cell-IQ™ Series 5.8 cu.ft. CO2 Laboratory Incubator units
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institute of Health, Clinical Center (NIH-CC) has issued a Special Notice indicating its intent to sole source the acquisition of 4 Cell-IQ™ Series 5.8 cu.ft. CO2 Laboratory Incubator units from LABREPCO LLC. This procurement is for the Critical Care medicine department in Bethesda, MD, to replace aging equipment. Capability statements from other responsible sources are due by June 30, 2026.
Scope of Work
The requirement is for four (4) Cell-IQ™ Series 5.8 cu.ft. CO2 Laboratory Incubator units. These new units will replace four HERAcell 150i incubators that were installed in 2011 and are now due for replacement under the agency's equipment replacement plan.
Contract & Timeline
- Type: Special Notice (Intent to Sole Source)
- Statutory Authority: 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1 (only one responsible source)
- Intended Vendor: LABREPCO LLC
- Set-Aside: None specified (sole source intent)
- Response Due: June 30, 2026, by 12:00 PM Eastern Standard Time
- Published: June 15, 2026
- Place of Performance: Bethesda, MD 20892, United States
Evaluation
This is not a Request for Proposal. The government will consider capability statements submitted by any responsible source that believes they can provide the required units. A determination not to compete this requirement, based on responses to this notice, is solely at the discretion of the Government.
Additional Notes
Capability statements should be submitted via email to valerie.gregorio@nih.gov, with the subject line referencing "NOI-OLAO-CC-26-006921."